---
title: "Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295848659.md"
description: "Charles River Laboratories (CRL) stock fell 1.09% to $281.27 on Thursday, underperforming the broader market and its peers despite a positive trading session. This decline ended a seven-day winning streak. CRL closed 2.34% below its 52-week high of $288.02. In comparison, competitors Labcorp, Alnylam, and Bio-Techne showed mixed results. Trading volume for CRL was 1.1 million shares, exceeding its 50-day average."
datetime: "2026-08-13T21:15:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295848659.md)
  - [en](https://longbridge.com/en/news/295848659.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295848659.md)
generator: "portal-rs"
---

# Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. (CRL) slipped 1.09% to $281.27 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.65% to 7,798.99 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.

The stock's fall snapped a seven-day winning streak.

Charles River Laboratories International Inc. closed 2.34% below its 52-week high of $288.02, which the company achieved on August 12th.

The stock underperformed when compared to some of its competitors Thursday, as Labcorp Holdings Inc. (LH) fell 0.28% to $322.59, Alnylam Pharmaceuticals Inc. (ALNY) rose 1.42% to $227.12, and Bio-Techne Corp. (TECH) fell 0.08% to $72.17.

Trading volume (1.1 M) eclipsed its 50-day average volume of 882,615.

Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-13-26 1714ET

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [LH.US](https://longbridge.com/en/quote/LH.US.md)
- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)

## Related News & Research

- [Insider Move at Charles River Labs: Director Cashes In on Company Stock](https://longbridge.com/en/news/296571643.md)
- [Charles River Labs director Nancy C. Andrews disposes of 573 common shares worth $163,442.52](https://longbridge.com/en/news/296533503.md)
- [If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/295982117.md)
- [Charles River and MVC to develop enterovirus vaccine](https://longbridge.com/en/news/296594849.md)
- [Charles River partners with Medigen Vaccine Biologics on NGS-backed multivalent enterovirus vaccine development](https://longbridge.com/en/news/296486690.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**